Legacy Effects of CALERIE, a 2-year Calorie Restriction Intervention, on Hallmarks of Healthspan and Aging
CALERIE(一种为期 2 年的热量限制干预措施)对健康寿命和衰老标志的遗留影响
基本信息
- 批准号:10365580
- 负责人:
- 金额:$ 133.18万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-09-30 至 2026-05-31
- 项目状态:未结题
- 来源:
- 关键词:AddressAdultAerobicAgeAgingAlgorithmsAnimal ModelAttenuatedBaltimoreBasal metabolic rateBiologicalBiological AgingBiological MarkersBiological Specimen BanksBloodBody CompositionBody measure procedureBrain natriuretic peptideC-reactive proteinCaloric RestrictionCardiometabolic DiseaseCell AgingChronic DiseaseClinical TrialsCognitionCommunitiesControl GroupsDevelopmentDiseaseEnergy IntakeExposure toFatigueFollow-Up StudiesFundingGDF15 geneGait speedGeneral PopulationGlycosylated hemoglobin AGoalsHand StrengthHumanInsulinInsulin-Like Growth Factor IIntakeInterleukin-6InterventionIsoprostanesLong-Term EffectsLongitudinal StudiesMeasurementMeasuresMetabolic syndromeMetforminMethodsN-terminalNational Institute on AgingNutritionalObesityObservational StudyOutcomeOxidative StressParticipantPatternPhenotypeProcessProteinsPublic HealthQuality ControlQuality of lifeRandomized Controlled TrialsRiskSamplingSleepTNFRSF1A geneTestingUrineage relatedbehavior changebiobehaviorblood-based biomarkercardiorespiratory fitnesscognitive functioncohortcomparison groupdata repositorydesigndiet and exercisedisorder riskeffectiveness evaluationexperiencefollow-uphealthspanhealthy agingindexingintervention participantslifestyle interventionmiddle agemotivated behaviornovelpost gamma-globulinspreventprimary outcomepsychologicsenescenceurinary
项目摘要
PROJECT SUMMARY
Calorie restriction (CR) is a promising nutritional strategy with the potential to slow the aging process. The
Comprehensive Assessment of Long-term Effects of Reducing Intake of Energy (CALERIE) trial, funded by the
National Institute on Aging, was the first clinical trial to demonstrate the feasibility of achieving sustained,
moderate CR in healthy, young and middle-aged adults without obesity. During the 2-year CR intervention,
participants achieved 12% CR on average and, compared to an ad libitum intake control group, experienced
remarkable improvements in markers of healthspan and a slower rate of biological aging. The overarching goal
of this proposed study is to examine whether 2 years of CR results in long-term improvements in the biological,
phenotypic, and functional hallmarks of human aging. We hypothesize that exposure to a 2-year CR
intervention in early to mid-adulthood results in sustained lower rates of biological aging, delayed
manifestations of phenotypic aging, superior indices of functional aging, and greater quality of life compared to
ad libitum intake. To test this hypothesis, we will conduct an observational follow-up study of CALERIE
participants 10 to 15 years after the end of their trial participation. Participants from the CALERIE CR group will
be compared with an ad libitum intake comparison group composed of the CALERIE ad libitum control group
and a matched community-dwelling cohort from the Baltimore Longitudinal Study of Aging (BLSA). The well-
characterized BLSA cohort is included as a comparison sample to address the concern that the highly
screened CALERIE controls may have been healthier than the general population and highly motivated for
behavior change. The BLSA also has the rigor, quality control, and several of the same outcome
measurements as the CALERIE trial to facilitate comparisons. The proposed CALERIE follow-up study will
include a comprehensive set of physical and functional assessments, including resting metabolic rate, body
composition, cardiorespiratory fitness, grip strength, and cognitive function, in addition to psychological and
quality-of-life measures. Blood and urine also will be collected and analyzed for markers of biological aging and
cardiometabolic disease risk. Comparisons will be made between CALERIE CR participants and the combined
ad libitum intake comparison group (the CALERIE ad libitum control group and the BLSA cohort). Evaluating
legacy effects of the CALERIE trial will determine the effectiveness of a CR intervention in early to mid-
adulthood for preventing the development or delaying the progression of age-related chronic disease. The
proposed trial will augment the CALERIE data and biospecimen repository for future research to advance our
understanding of human aging.
项目摘要
卡路里限制(CR)是一种有希望的营养策略,有可能减慢衰老过程。这
全面评估减少能源摄入量(Calerie)试验的长期影响,由
美国国家衰老研究所是第一个证明实现持续的可行性的临床试验
在没有肥胖症的健康,年轻和中年成年人中,CR中等。在两年的CR干预期间,
参与者平均获得了12%的CR,并且与自发摄入对照组相比
HealthSpan的标志物和生物衰老速度较慢的标志都显着改善。总体目标
这项拟议的研究是检查2年的CR是否会导致生物学的长期改善,
表型和人类衰老的功能标志。我们假设暴露于2年CR
干预早期至中期导致持续的生物老化率较低,延迟
与表型衰老的表现,功能衰老的出色指标以及更高的生活质量相比
随意摄入。为了检验这一假设,我们将对热量的观察性随访研究
参与者参加试验结束后10到15年。 Calerie CR组的参与者将
将其与自由摄入比较组组成
以及来自巴尔的摩衰老纵向研究(BLSA)的匹配的社区居民队列。福
包括BLSA队列的特征作为比较样本,以解决高度的关注
筛选的热量控制可能比普通人群更健康,并且有高度动力
行为改变。 BLSA还具有严格的质量控制和几个相同的结果
测量作为钙化试验,以促进比较。拟议的热门随访研究将
包括一组全面的身体和功能评估,包括静息代谢率,身体
除了心理和心理和
生活质量措施。还将收集和分析血液和尿液的生物衰老和
心脏代谢疾病风险。将在Calerie CR参与者和合并的合并中进行比较
自发摄入比较组(库列氏症对照组和BLSA队列)。评估
Calerie试验的遗产影响将决定CR干预在早期至中期的有效性
为防止发展或延迟与年龄相关的慢性疾病的发展的成年。这
拟议的试验将增强卡尔丽数据和生物循环库以未来的研究,以促进我们的
对人类衰老的理解。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Sai Krupa Das其他文献
Sai Krupa Das的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Sai Krupa Das', 18)}}的其他基金
Clinical Center for NIH's Nutrition for Precision Health: The All Of Us New England Research Collaborative
美国国立卫生研究院精准健康营养临床中心:我们所有人新英格兰研究合作组织
- 批准号:
10384446 - 财政年份:2021
- 资助金额:
$ 133.18万 - 项目类别:
Clinical Center for NIH's Nutrition for Precision Health: The All Of Us New England Research Collaborative
美国国立卫生研究院精准健康营养临床中心:我们所有人新英格兰研究合作组织
- 批准号:
10539337 - 财政年份:2021
- 资助金额:
$ 133.18万 - 项目类别:
Self-selected diet composition, adherence to caloric restriction, and cardiometabolic disease risk
自我选择的饮食结构、坚持热量限制和心脏代谢疾病风险
- 批准号:
9807563 - 财政年份:2019
- 资助金额:
$ 133.18万 - 项目类别:
相似国自然基金
成人型弥漫性胶质瘤患者语言功能可塑性研究
- 批准号:82303926
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
MRI融合多组学特征量化高级别成人型弥漫性脑胶质瘤免疫微环境并预测术后复发风险的研究
- 批准号:82302160
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
成人免疫性血小板减少症(ITP)中血小板因子4(PF4)通过调节CD4+T淋巴细胞糖酵解水平影响Th17/Treg平衡的病理机制研究
- 批准号:82370133
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
SMC4/FoxO3a介导的CD38+HLA-DR+CD8+T细胞增殖在成人斯蒂尔病MAS发病中的作用研究
- 批准号:82302025
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
融合多源异构数据应用深度学习预测成人肺部感染病原体研究
- 批准号:82302311
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Copper Sensing in Uropathogenic Escherichia coli
尿路致病性大肠杆菌中的铜感应
- 批准号:
10604449 - 财政年份:2023
- 资助金额:
$ 133.18万 - 项目类别:
Precision Medicine in Alzheimer’s Disease: A SMART Trial of Adaptive Exercises and Their Mechanisms of Action Using AT(N) Biomarkers to Optimize Aerobic-Fitness Responses
阿尔茨海默病的精准医学:使用 AT(N) 生物标志物优化有氧健身反应的适应性运动及其作用机制的 SMART 试验
- 批准号:
10581973 - 财政年份:2023
- 资助金额:
$ 133.18万 - 项目类别:
Nitrite Supplementation to Mitigate Fatigability and Increase Function in Long COVID Patients
补充亚硝酸盐可减轻长期新冠患者的疲劳并增强功能
- 批准号:
10590380 - 财政年份:2023
- 资助金额:
$ 133.18万 - 项目类别:
MIND Foods and Aerobic Training in Black Adults with HTN: An ADRD Prevention Pilot RCT (MAT)
MIND 食品和患有 HTN 的黑人成人的有氧训练:ADRD 预防试点随机对照试验 (MAT)
- 批准号:
10585366 - 财政年份:2023
- 资助金额:
$ 133.18万 - 项目类别:
Adapting and Implementing a Nurse Care Management Model to Care for Rural Patients with Chronic Pain
适应和实施护理管理模式来护理农村慢性疼痛患者
- 批准号:
10741606 - 财政年份:2023
- 资助金额:
$ 133.18万 - 项目类别: